SCM
NAUT icon

Sterling Capital Management’s Nautilus Biotechnolgy NAUT Stock Holding History

Sterling Capital Management’s Portfolio NAUT Stock Details NAUT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.72K Buy
+922
New +$2.43K ﹤0.01% 3030
2025
Q2 		– Sell
-875
Closed -$753 – 3344
2025
Q1 		$753 Sell
875
-780
-47% -$1.16K ﹤0.01% 2895
2024
Q4 		$2.78K Buy
1,655
+1,501
+975% +$3.59K ﹤0.01% 2679
2024
Q3 		$439 Buy
+154
New +$399 ﹤0.01% 2927

Other funds holding NAUT

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
ACM
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return
CM
Cercano Management Bellevue, Washington $750M AUM 25.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CFM
Comprehensive Financial Management Los Gatos, California $3.05B AUM 1.77% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
CA
Clearstead Advisors Cleveland, Ohio $10.6B AUM 24.87% 1-Year Est. Return

Sterling Capital Management's NAUT Position: Q2 2026 in Review

Sterling Capital Management opened a new position in Nautilus Biotechnolgy (NAUT) in Q2 2026: 922 shares worth $1.72K. The stake represents ﹤0.01% of the portfolio and ranks #3030 among its holdings. This is a return to the name: Sterling Capital Management previously reported a position in NAUT as recently as Q1 2025.

Sterling Capital Management first reported a position in NAUT in Q3 2024 and has held it in 4 quarters since. The position peaked at $2.78K in Q4 2024. 93 funds tracked by Wall St. Rank hold NAUT as of Q2 2026.

  • Sterling Capital Management held 922 shares of Nautilus Biotechnolgy worth $1.72K as of Q2 2026.
  • Nautilus Biotechnolgy was a new Sterling Capital Management position in Q2 2026.
  • Nautilus Biotechnolgy made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #3030 holding.
  • Sterling Capital Management first reported a position in Nautilus Biotechnolgy in Q3 2024 and has held it in 4 quarters since.
  • Sterling Capital Management's Nautilus Biotechnolgy position peaked at $2.78K in Q4 2024.
  • 93 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.